Yesterday, Ontario agreed to cover the cost of Axicabtagene Ciloleucel for the treatment of certain types of aggressive non-Hodgkin lymphoma.
Lymphoma Canada applauds provinces that have made this CAR-T cell therapy available for patients inside their home province, including Ontario who just agreed to cover the cost.
Advocates would like equitable access to treatment across all provinces and territories, including Manitoba.
CART cell therapy made the difference for this one Winnipegger, Bob Plamondon, and others who may not have any treatment options left.
